Antibiotic-Resistant Escherichia coli in Women with Acute Cystitis in Canada

BACKGROUND: Trimethoprim-sulfamethoxazole (TMP-SMX) has been a traditional first-line antibiotic treatment for acute cystitis; however, guidelines do not recommend TMP-SMX in regions where Escherichia coli resistance exceeds 20%. While resistance is increasing, there are no recent Canadian estimates...

Full description

Saved in:
Bibliographic Details
Main Authors: Warren J McIsaac, Rahim Moineddin, Christopher Meaney, Tony Mazzulli
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2013/547848
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555057345724416
author Warren J McIsaac
Rahim Moineddin
Christopher Meaney
Tony Mazzulli
author_facet Warren J McIsaac
Rahim Moineddin
Christopher Meaney
Tony Mazzulli
author_sort Warren J McIsaac
collection DOAJ
description BACKGROUND: Trimethoprim-sulfamethoxazole (TMP-SMX) has been a traditional first-line antibiotic treatment for acute cystitis; however, guidelines do not recommend TMP-SMX in regions where Escherichia coli resistance exceeds 20%. While resistance is increasing, there are no recent Canadian estimates from a primary care setting to guide prescribing decisions.
format Article
id doaj-art-7cf34722e24a41bc9c710c43142ea156
institution Kabale University
issn 1712-9532
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj-art-7cf34722e24a41bc9c710c43142ea1562025-02-03T05:49:46ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322013-01-0124314314910.1155/2013/547848Antibiotic-Resistant Escherichia coli in Women with Acute Cystitis in CanadaWarren J McIsaac0Rahim Moineddin1Christopher Meaney2Tony Mazzulli3Granovsky-Gluskin Family Medicine Centre, Ray D Wolfe Department of Family Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, CanadaDepartment of Community and Family Medicine, University of Toronto, Toronto, Ontario, CanadaDepartment of Community and Family Medicine, University of Toronto, Toronto, Ontario, CanadaDepartment of Microbiology, Mount Sinai Hospital and University Health Network, Toronto, Ontario, CanadaBACKGROUND: Trimethoprim-sulfamethoxazole (TMP-SMX) has been a traditional first-line antibiotic treatment for acute cystitis; however, guidelines do not recommend TMP-SMX in regions where Escherichia coli resistance exceeds 20%. While resistance is increasing, there are no recent Canadian estimates from a primary care setting to guide prescribing decisions.http://dx.doi.org/10.1155/2013/547848
spellingShingle Warren J McIsaac
Rahim Moineddin
Christopher Meaney
Tony Mazzulli
Antibiotic-Resistant Escherichia coli in Women with Acute Cystitis in Canada
Canadian Journal of Infectious Diseases and Medical Microbiology
title Antibiotic-Resistant Escherichia coli in Women with Acute Cystitis in Canada
title_full Antibiotic-Resistant Escherichia coli in Women with Acute Cystitis in Canada
title_fullStr Antibiotic-Resistant Escherichia coli in Women with Acute Cystitis in Canada
title_full_unstemmed Antibiotic-Resistant Escherichia coli in Women with Acute Cystitis in Canada
title_short Antibiotic-Resistant Escherichia coli in Women with Acute Cystitis in Canada
title_sort antibiotic resistant escherichia coli in women with acute cystitis in canada
url http://dx.doi.org/10.1155/2013/547848
work_keys_str_mv AT warrenjmcisaac antibioticresistantescherichiacoliinwomenwithacutecystitisincanada
AT rahimmoineddin antibioticresistantescherichiacoliinwomenwithacutecystitisincanada
AT christophermeaney antibioticresistantescherichiacoliinwomenwithacutecystitisincanada
AT tonymazzulli antibioticresistantescherichiacoliinwomenwithacutecystitisincanada